Editorial Board ::: Current Pharmaceutical Design

ISSN: 1873-4286 (Online)
ISSN: 1381-6128 (Print)


Volume 23, 46 Issues, 2017


Download PDF Flyer




Current Pharmaceutical Design

This journal supports open access

Aims & ScopeAbstracted/Indexed in

Ranking and Category:
  • 73rd of 253 in Pharmacology & Pharmacy

Submit Abstracts Online Submit Manuscripts Online

Editor-in-Chief:
William A. Banks
VAPSHCS/GRECC S-182
Building 1, Room 810A
1600 S. Columbian Way
Seattle, WA 98108
USA


View Full Editorial Board

Subscribe Purchase Articles Order Reprints

Current: 3.052
5 - Year: 3.132

Editorial Board

Editor-in-Chief:

William A. Banks (Biography
William A. Banks

Dr. Banks obtained his MD from the University of Missouri- Columbia and did clinical and research training at the Veterans Affairs Medical Center – New Orleans and Tulane University. He is currently Associate Chief of Staff –Research and Development at the Puget Sound VA and Professor of Medicine at University of Washington School of Medicine. His main interest is in blood-brain barrier function. He has published over 450 non-abstract articles, and over 20,000 citations according to Web of Science with an H-index fo 81.

)

VAPSHCS/GRECC S-182
Building 1, Room 810A
1600 S. Columbian Way
Seattle, WA 98108
USA



Regional Editors:

Region: Asia
Seiji Shioda (Biography
Seiji Shioda

Dr. Seiji Shioda obtained a doctorate (Ph.D) in Medical Science in Showa University School of Medicine, Tokyo. Currently Dr. Shioda is professor of Hoshi University, Global Research Center for Innovative Science (GRIL), Peptides Drug Innovation. Dr. Shioda is also an Adjunct Professor of Tulane University Medical School. He has published more than 500 scientific publications and is a named inventor of 10 issued Japanese patents. Dr. Shioda has been the Regional Editor (Asia) of Current Pharmaceutical Design, published by Bentham Science Publishers.

)

Hoshi University
Tokyo
Japan
Region: Europe
Dimitri Mikhailidis (Biography
Dimitri Mikhailidis

Dimitri Mikhailidis graduated from the University of London (BSc, MSc, MB,BS and MD) and is Academic Head, Department of Clinical Biochemistry, Royal Free Hospital campus, University College London Medical School. He is also a Visiting Professor, Univ. of Belgrade, Serbia and at two universities in Saudi Arabia. His research interests are dyslipidaemias and thrombosis.

He is a Fellow of the Royal College of Pathologists (FRCPath), Royal College of Physicians (FRCP), Faculty of Pharmaceutical Medicine (FFPM) and American College of Clinical Pharmacology (FCP). He has 22,118 citations on the ISI index, Core Collection (H-factor 64).

)

Royal Free Hospital
London
UK

Section Editors:

(HIV Agents)
Howard Gendelman (Biography
Howard Gendelman

Dr. Howard E. Gendelman is the Margaret R. Larson Professor of Internal Medicine and Infectious Diseases and Chairman of the Department of Pharmacology and Experimental Neuroscience at the University of Nebraska Medical Center. He is credited in unraveling how functional alterations in brain immunity induce metabolic changes and ultimately lead to neural cell damage for a broad range of infectious and neurodegenerative disorders. These discoveries have led to novel therapeutics aimed at reversing neural maladies. He obtained a Bachelor’s degree in Natural Sciences and Russian Studies from Muhlenberg College and his M.D. from the Pennsylvania State University where he was the 1999 Distinguished Alumnus.

)

University of Nebraska Med. Ctr
Omaha, NE
USA

(Nanotechnology)
Alexander V. Kabanov
University of North Carolina at Chapel Hill
Chapel Hill, NC
USA

(Anti-hypertensive Agents)
Gregory Lip
City Hospital
Birmingham
UK

(Computer Assisted Drug Design)
Rami Reddy (Biography
Rami Reddy

Dr. Reddy obtained a doctorate (Ph. D.) in Computational Chemistry from the Central University of Hyderabad, Hyderabad, India. Dr. Reddy is a founder of Rational Labs and is highly accomplished computational Chemist with a proven track record in drug discovery and CADD software development. Dr. Reddy has over 25 years of experience in drug discovery working in several Pharmaceutical and Biotech companies such as Agouron Pharmaceuticals (now Pfizer), Gensia Pharmaceuticals, Metabasis Therapeutics and Rational Labs. Dr. Reddy’s drug discovery efforts have resulted in one marketed drug for AIDS and several clinical compounds for cancer and diabetes. Dr. Reddy is an author of over 100 publications and patents.

)

RR Labs Inc
San Diego, CA
USA

(Immune Agents)
Emilio Jirillo (Biography
Emilio Jirillo

Emilio Jirillo is full professor of Immunology at University of Bari Medical School (Bari, Italy) since 1986.His current fields of interest are: mucosal immunity, microbial immunity and immunonutrition.Especially in this last field, he has recently published in vitro and in vivo studies on the anti inflammatory effects of polyphenols . He is author of more than 560 papers(326 scientific papers are listed in PUBMED), even including books and chapters of books. He is editor-in-chief- of the following Bentham journals:1. Endocrine Metabolic Immune Disorders-Drug Targets ; 2.Clinical Immunology Endocrine Metabolic Drugs.

)

Bari University
Bari
Italy

(Endocrine and Metabolic Agents)
Abba Kastin (Biography
Abba Kastin

Abba J. Kastin was born in Ohio and educated at Harvard College and Harvard Medical School. After starting his work on neuropeptides as a Clinical Associate at NIH, he went to Louisiana where he now holds an endowed chair at the Pennington Biomedical Research Center. In recognition of the concepts he introduced into the field of biologically active peptides, Dr. Kastin has been made an honorary member of 9 foreign medical societies, has received 2 honorary professorships and 3 honorary doctorates (the last one from Uppsala University), and has won several national and international awards. Author of more than 900 papers cited more than 34,500 times (H index 87), he has been listed among the 100 researchers most cited in the scientific literature. He is president of The International Neuropeptide Society/Society for Biologically Active Peptides and was founding Editor-in-Chief of the international journal Peptides for 35 years.

)

Pennington Biomed. Res. Ctr., Baton Rouge
LA
USA

(Cardiovascular/Hematologic Agents)
Dimitri Mikhailidis (Biography
Dimitri Mikhailidis

Dimitri Mikhailidis graduated from the University of London (BSc, MSc, MB,BS and MD) and is Academic Head, Department of Clinical Biochemistry, Royal Free Hospital campus, University College London Medical School. He is also a Visiting Professor, Univ. of Belgrade, Serbia and at two universities in Saudi Arabia. His research interests are dyslipidaemias and thrombosis.

He is a Fellow of the Royal College of Pathologists (FRCPath), Royal College of Physicians (FRCP), Faculty of Pharmaceutical Medicine (FFPM) and American College of Clinical Pharmacology (FCP). He has 22,118 citations on the ISI index, Core Collection (H-factor 64).

)

Royal Free Hospital
London
UK


Editorial Board Members:

Vasilios G. Athyros
Aristotelian University, Medical School
Thessaloniki
Greece

Steven J. Brickner
University of New South Wales
Groton, CT
USA

Stevan W. Djuric (Biography
Stevan W. Djuric

Dr. Djuric received a doctorate (PhD) in chemistry from the University of Leeds (UK) followed by a postdoctoral fellowship with Professor Philip D Magnus at the Ohio State University. He holds an Adjunct Professorship in the Department of Medicinal Chemistry at the University of Kansas. He is head of the global AbbVie Medicinal Chemistry Leadership team and is also responsible for the Discovery Chemistry and Technology organization within their Discovery organization He has over 180 scientific publications, presentations and patents. He has given over 30 invited lectures at universities and national meetings. He is a member of several Editorial Advisory Boards including the journal of Medicinal Chemistry, ACS Medicinal Chemistry Letters and Current Pharmaceutical Design.

)

Abbott Laboratories
Abbott Park, IL
USA

Nigel H. Greig (Biography
Nigel H. Greig

Nigel H. Greig (Ph.D. Pharmacology, University of London, England) heads the Drug Design & Development Section within the Translational Gerontology Branch, Intramural Research Program, National Institute on Aging, National Institutes of Health. Located in Baltimore, MD, USA, his program combines cellular, molecular and in vivo pharmacology with medicinal chemistry to design and development novel experimental drugs against rate-limiting steps involved in the pathophysiology of diseases associated with aging, with an emphasis on the nervous system. Nigel, together with his exceptional collaborators and research group have successfully moved multiple experimental drugs from concept through preclinical studies and into human clinical trials.

)

National Institutes of Health
Baltimore, MD
USA

Keith W. Kelley (Biography
Keith W. Kelley

Keith W. Kelley is a Professor Emeritus of Immunophysiology at the University of Illinois. Dr. Kelley earned his Ph.D. in 1976, a time when the immune system was considered only to protect against infectious diseases. He helped reshape that view by bringing physiology to immunology. It is now accepted that there is an active dialogue between the immune system and brain, and these discoveries are improving human and animal health. Professor Kelley has been honored with 10 university and national awards, published more than 250 peer-reviewed scientific papers as well as 70 book chapters, is well cited with an h-index of 68, been funded for 50 years as the Principal Investigator of NIH grants and served on four dozen NIH study sections. He is currently a Full Member of the Neuroendocrinology, Neuroimmunology, Rhythms and Sleep Study Section. Dr. Kelley is a Past-President and Secretary-Treasurer of the PsychoNeuroImmunology Research Society. He has been Editor-in-Chief of Brain, Behavior, and Immunity since 2003. The latest impact factor of the journal is 5.9, ranking it in the top 14% of all immunology journals and 11% of neuroscience journals.

)

University of Illinois
IL
USA

JoEllyn McMillan (Biography
JoEllyn McMillan

Dr. McMillan earned a Ph.D. in Toxicology from Texas A&M University, College Station, TX, USA. She held a post-doctoral fellowship at the National Center for Toxicological Research, Jefferson AR, USA, and a second post-doctoral fellowship in the Department of Pharmacology and Experimental Therapeutics, College of Medicine, at the Medical University of South Carolina, Charleston SC, USA. She remained at the Medical University of South Carolina as an Assistant Professor in the Pharmacology Department and then moved to the University of Nebraska Medical Center, Omaha, NE, USA, in 2007. She holds a joint appointment in the Department of Pharmacology and Experimental Neuroscience, College of Medicine, and the Department of Environmental, Agricultural and Occupational Health, College of Public Health. She has authored/coauthored over 70 scientific publications and book chapters.

)

University of Nebraska Medical Center
Omaha, NE
USA

Ruth Nussinov (Biography
Ruth Nussinov

Ruth Nussinov graduated from Rutgers, was in the Weizmann Institute, the Chemistry Department at Berkeley and Biochemistry at Harvard. She joined the Medical School in Tel Aviv and accepted a concurrent position at the National Cancer Institute, Leidos. She has co-authored over 550 papers. She is the Editor-in-Chief in PLoS Computational Biology, and an Associate Editor and on the Editorial Boards of several journals. She is a frequent speaker in Domestic and International meetings, symposia and academic institutions, won several awards and elected fellow of several societies. Her National Cancer Institute website describes her science, and major contributions. https://ccr.cancer.gov/ruth-nussinov.

)

National Cancer Institute
Frederick, MD
USA

Matteo Antonio Russo (Biography
Matteo Antonio Russo

Prof. Matteo A. Russo obtained his Medical Degree from Catholic University Medical School in Rome (Italy). He specialized in Oncology, General Pathology (from University of Rome Sapienza) and Cardiology (Catholic University Medical School). Soon after he got a track tenure at University of Rome Sapienza Medical School, first, as Associate Professor of Experimental Oncology and then as Full Professor of General Pathology. At present, he is the Head of Basic Research and Laboratories at San Raffaele Scientific Institute; he is also President of MEBIC (Medical and Experimental Bioimaging Center, a joint consortium between San Raffaele University and University of Rome Tor Vergata). He has published more than 150 scientific papers, being awarded by three international prizes for Basic Research. Prof. Russo is member of the editorial board of 6 peer-reviewed journals.

)

IRCCS Foundation Rome, Molecular and Cell Biology Laboratory
Rome
Italy

Claudiu T. Supuran (Biography
Claudiu T. Supuran

is professor of medicinal chemistry at the Neurofarba Department, Section of Pharmaceutical and Nutriceutical Sciences, University of Florence, Italy. He has published more than 1250 papers, his Hirsch factor is h = 110; the number of citations since 1995 > 49800. His main research interest is on enzyme inhibitors, and especially carbonic anhydrase inhibitors, of which he discovered several new classes in the last years. One of the sulfonamides discovered in his group entered Phase I clinical trials in 2014 for the treatment of advanced, metastatic solid tumors. He is Editor-in-Chief of Expert Opinion on Therapeutic Patents, Journal of Enzyme Inhibition and Medicinal Chemistry, Current Enzyme Inhibition, etc. For the last 25 years the main interest of his research was focused on metallo-enzymes and their modulators of activity. In 2013 he was rated as the most cited scientists in Pharmacology & Toxicology by LabTimes (LabTimes 2013, 5, 38).

)

Universita degli Studi di Firenze
Florence
Italy

Xiaojun Yao (Biography
Xiaojun Yao

Xiaojun Yao received his Ph.D. degree in chemoinformatics and theoretical chemistry from University Paris 7-Denis Diderot, Paris, France, in 2004. He works as a Professor of chemoinformatics and analytical chemistry in College of Chemistry and Chemical Engineering, Lanzhou University, Lanzhou, China. His current research interests include computer-aided molecular design, bioinformatics, and computational biology.

)

Lanzhou University
Lanzhou
China

Scott A. Biller
Novartis Institutes for BioMedical Research
Cambridge, MA
USA

Allan Butterfield (Biography
Allan Butterfield

Dr. Butterfield earned his Ph.D. at Duke University in physical chemistry followed by a NIH Postdoctoral Fellowship in neuroscience at the Duke University School of Medicine. In 1975, Dr. Butterfield joined the faculty of Chemistry at the University of Kentucky and rose to Full Professor in 1983. Prof. Butterfield is the UK Alumni Association Endowed Professor of Biological Chemistry and Associate Vice President for Research at UK. He is a faculty member of the Sanders-Brown Center on Aging. Prof. Butterfield has over 620 refereed scientific publications, mostly on oxidative stress in brain in subjects with Alzheimer disease and its earlier stages. Dr. Butterfield pioneered the field of redox proteomics, by which oxidatively modified proteins can be identified. He has edited five books, and published over 150 abstracts, most of which were refereed. His work has been continuously funded at the University of Kentucky by federal grants from NIH, NSF, and DoD as well as foundation grants. He has trained over 60 Ph.D and M.S. students and over 25 postdoctoral scholars and visiting scientists. He has received a Presidential Award for Excellence in Science Mentoring from President Clinton at the White House, and an Honorary Doctor of Science Degree from his undergraduate alma mater, the University of Maine. Prof. Butterfield was named the 39th most cited and influential researcher on Alzheimer disease in the world as cited in the Journal of Alzheimers Disease. He is on the editorial boards of 14 journals, including Current Pharmaceutical Design.

)

University of Kentucky
Lexington, KY
USA

Roland E. Dolle
Pharmacopeia, Inc
Princeton, NJ
USA

James M. Hamby
Parke-Davis, Pharm. Res
Ann Arbor, MI
USA

Marlys Koschinsky
Queen's University
Kingston
Canada

John E. Morley (Biography
John E. Morley

John E. Morley, MB, BCh, is the Dammert Professor of Gerontology, Director, Division of Geriatric Medicine and Director of the Division of Endocrinology at Saint Louis University School of Medicine. He serves as Medical Director for two nursing homes. Dr. Morley earned a medical degree at the University of Witwatersrand in Johannesburg, South Africa. He is board certified in Internal Medicine, Endocrinology and Geriatric Medicine. He has edited over 20 books, and published more than 1300 manuscripts. He has an h-factor of 107. He serves as Editor of Journal of the American Medical Directors Association, impact factor 6.61.

)

St. Louis University Health Sciences Center
St. Louis, MO
USA

Waldemar Priebe (Biography
Waldemar Priebe

Dr. Priebe obtained a Master of Science in Organic Chemistry degree from the University of Warsaw in Poland and a doctorate (Ph.D.) in Organic and Medical Chemistry from the Institute of Organic Chemistry, Polish Academy of Sciences in Poland. He is a Professor of Medicinal Chemistry at The University of Texas M. D. Anderson Cancer Center in Houston and also holds the title of Professor of Chemistry in the Republic of Poland. Prof. Priebe is noted for his successful development of new therapeutic entities for the treatment of cancer. Five of his drugs entered clinical trials and several others are in different stages of preclinical development. He has published more than 200 scientific publications and his work has led to over 50 patents.

)

University of Texas
Houston, TX
USA

Andrew V. Schally (Biography
Andrew V. Schally

Andrew V. Schally, Ph.D., M.D.h.c., received his training in England, Canada, Sweden, and USA. In the years 1954-1977 he worked in the field of neuroendocrinology. Dr. Schally’s group isolated and elucidated the structure of hypothalamic LHRH. Dr. Schally was awarded the Nobel Prize in Medicine in 1977 for his work on hypothalamic peptides. Dr. Schally switched then to cancer research. He is a world leader in research on hormone-related cancers and treatment of prostate and other cancers. Various classes of anticancer peptides were developed in his laboratory. Dr. Schally is the Professor of Pathology and Medicine at the University of Miami School of Medicine, Chief of the Endocrine, Polypeptide Cancer Institute at the VA Medical Center, Miami, Florida and Distinguished Medical Research Scientist. He has more than 2500 publications to his credit.

)

(Nobel Laureate)
VAMC
New Orleans, LA
USA

Nese Tuncel (Biography
Nese Tuncel

Dr. Neşe Tunçel received her BS in Pharmacy in 1970 and her PhD in Medical Physiology in 1982 from Ankara University, Turkey. She has been served as a Professor in the Department of Physiology and Neurophysiology, Faculty of Medicine, Eskis􏰁ehir Osmangazi University, and she was retired in April 2016. She has 95 scientific publications. She also serves as a member of the Editorial boards of several academic journals including Current Pharmaceutical Design, Medicinal Chemistry, Recent Patents on Anti-Cancer Drug Discovery, The Open Cancer Journal, Biomedical Review and Adipobiology, Current Clinical pharmacology. She has also served in the Editorial Advisory Board of Peptides in the period 1998-2010 and, Immunology, Endocrine and Metabolic Agents for three years.

)

Osmangazi University
Eskisehir
Turkey

Yuri V. Bobryshev (Biography
Yuri V. Bobryshev

Prof. Bobryshev obtained a doctorate (Dr.Sc.) from the Institute of General Pathology and Pathophysiology, the Russian Academy of Medical Sciences. Currently Dr Bobryshev is a Senior Research Associate of the Faculty of Medicine, University of New South Wales, Sydney, Australia and Adjunct Associate Professor of the School of Medicine, University of Western Sydney, Australia. Dr Bobryshev is a Fellow of Faculty of Science of the Royal College of Pathologists of Australasia (RCPA). Dr Bobryshev has published more than 300 scientific publications.

)

University of New South Wales
Sydney
Australia

Elisabeth G.E. De Vries
Univ. of Groningen
Groningen
Netherlands

Catherine L. Farrell
Amgen, Inc., Thousand Oaks
CA
USA

Tingjun Hou (Biography
Tingjun Hou

Dr. Hou obtained a doctorate (Ph.D.) in Computational Chemistry from Peking University in 2002 and is currently the professor for College of Pharmaceutical Sciences at Zhejiang University in Hangzhou. His research focuses on development of new methods for computer-aided drug design (CADD) and design of potential lead compounds for important drug targets. He has published more than 260 peer reviewed papers in international prestigious SCI-cited journals, 4 book chapters and 1 multimedia courseware.

)

Soochow University
Suzhou, Jiangsu
China

Kit S. Lam
UC Davis Cancer Center
Sacramento, CA
USA

John H. Musser
Glycomed
Alameda, CA
USA

Manfredi Rizzo (Biography
Manfredi Rizzo

Prof. Rizzo is Associate Professor of Internal Medicine at the School of Medicine, University of Palermo, Italy as well as Associate Professor of Internal Medicine at the School of Medicine, University of South Carolina, USA. Prof. Rizzo sits on the editorial board of 9 international journals with Impact Factor. He has been the recipient of national and international fellowships and awards, and acted as reviewer for 100+ scientific international journals. The research work of Dr. Rizzo combines translational research (focus on the effects and mechanisms of action of lipid-lowering and anti‐diabetic agents) and basic research (focus on novel cardiovascular risk factors), with 200+ scientific publications with Impact Factor (total Impact Factor: >700. H‐Index: 42).

)

University of Palermo
Palermo
Italy

Claudio Soto (Biography
Claudio Soto

Dr Claudio Soto is Professor of Neurology and Director of the Mitchell Center for Alzheimer’s disease and related Brain Disorders at the University of Texas in Houston. He received his PhD from the University of Chile in 1993. His research focuses in understanding the molecular basis of neurodegenerative diseases associated to the misfolding and aggregation of proteins, particularly Alzheimer’s and prion disorders. He has published more than 160 peer review articles, many of which have been published in prestigious scientific journals (including Cell, Nature, Science, New England Journal of Medicine, Nature medicine, Lancet, etc). Dr Soto's publications have been cited more than 12,000 times (H index 59). He has been awarded many grants from NIH, and private foundations for a total funding of over 30 million dollars, and has been invited speaker in more than 160 scientific meetings worldwide.

)

University of Texas Medical Branch
Galveston, TX
USA

Antonino Tuttolomondo
Università degli Studi di Palermo
Palermo
Italy


Executive Guest Editor(s):

Umberto Aguglia / Ettore Beghi
(Italy)

Issue Title: Novel Perspectives in the Treatment of Epilepsy



Karel Allegaert / John Van Den Anker
(Belgium / USA)

Issue Title: Neonatal Clinical Pharmacology



Marco Alves
(Portugal)

Issue Title: The Aging Male Physiology, Pathophysiology and Therapeutic Perspectives



Maciej Banach / Maria-Corina Serban / Amirhossein Sahebkar
(Poland / Romania / Iran)

Issue Title: Natural Products in Health and Disease



Lillian Barros / Isabel Ferreira
(Portugal)

Issue Title: Phytochemicals and their Effects on Human Health



Loredana De Bartolo / Simona Salerno
(Italy)

Issue Title: Nanotechnology and Biomaterials for Cell and Drug Therapy



Stefanos Bonovas / Georgios Nikolopoulos
(Italy / Greece)

Issue Title: HIV and Antiretroviral Drugs: Current Status and New Challenges



Li Yue-Chun
(China)

Issue Title: Inflammation and Heart Diseases



Jose Correa
(Mexico)

Issue Title: Nanoparticles-dendrimers for Pharmaceutical uses



João Eurico Cortez Cabral da Fonseca / Joao Goncalves
(Portugal)

Issue Title: The Explosion of Biosimilars in Immune Mediated Chronic Inflammatory Diseases



Martin Federico Desimone / Gorka Orive
(Argentina / Spain)

Issue Title: Recent Advances and Innovative Strategies Applied in the Development of Biomaterials



Dominico Di Raimondo
(Italy)

Issue Title: Management of Elevated Heart Rate in Essential Hypertension: Pathophysiological Insights and Therapeutic Approach



Claudia Nunes dos Santos / Regina Menezes
(Portugal)

Issue Title: Polyphenols as new Leads in Drug Discovery: Biological Activity and Mechanisms



Marcos André Vannier dos Santos
(Brazil)

Issue Title: Parasite Polyamines as Pharmaceutical Targets



Ahmed Elzoghby
(Egypt)

Issue Title: Polymeric Nanocarriers as Robust Platforms for Cancer Therapy



Ana Raquel Esteves
(Portugal)

Issue Title: New Avenues and Therapeutic Strategies for the Treatment of Neurodegenerative Diseases



Davide Grassi
(Italy)

Issue Title: Nutraceuticals in Human Health (Polyphenols as Nutraceuticals)



Andrzej Grzybowski
(Poland)

Issue Title: Hot topics in Ocular Pharmacology



Pierre Guertin
(Canada)

Issue Title: Spinal Locomotor Systems



Ignacio Zapardiel Gutiérrez
(Spain)

Issue Title: Current Drugs and Products used for Sentinel Node Mapping in Gynaecological Cancers



Shilei Hao
(China)

Issue Title: Review Intracerebral Haemorrhage (ICH): Mechanisms of Injury and Therapeutic Targets



Jiman He
(China)

Issue Title: Common Therapeutic Targets for both Insulin Resistance and Cancer



Syed Vahid Hosseini
(Switzerland)

Issue Title: Emerging Technologies in Drug Delivery and Screening



Zunnan Huang
(China)

Issue Title: Recent Advances in the Field of Kinases and Kinase Inhibitors



Mohammad Amjad Kamal / Nigel H. Greig
(Australia / USA)

Issue Title: Frontier Views in Designing Therapeutic Candidates for Management of Diverse Diseases



Theodora Katsila / George Patrinos
(Greece)

Issue Title: Pharmacometabolomics in Precision Medicine



Takeshi Kurose
(Japan)

Issue Title: Advances in Diabetes related Membrane Receptor Signaling



Julia Kzhyshkowska / Ron N. Apte / Mariano Bizzarri / Nadezda Cherdyntseva
(Germany / Israel / Italy / Russia)

Issue Title: Targeting of Cancer Cells and Tumor Microenvironment: Perspectives for Personalized Therapy



Binbin Li
(China)

Issue Title: New Strategies for the Prevention and Treatment of Bone Loss



Aurelio Leone / Luigi Landini
(Italy)

Issue Title: Modifying Cardiovascular Risk Factors: Acquired Topics and Emerging Concepts



Dejia Li
(China)

Issue Title: Towards miRNA-Based Therapeutics for Lung Cancer



Jesus Fernandez Lucas
(Spain)

Issue Title: New Trend in Enzymatic Synthesis of Nucleic Acid Derivatives



Soraya Vallés Marti
(Spain)

Issue Title: Signaling Mechanisms of Brain Inflammation



Ikuko Miyazaki
(Japan)

Issue Title: Astrocyte-targeted Therapeutic Strategies for Neurological Disorders



Joseph Fomusi Ndisang
(Canada)

Issue Title: The different Facets of Diabetes, Dyslipidemia and Hypertension in Cardio-metabolic Diseases: Current Perspective and Future Developments



Hisham Al-Obaidi
(UK)

Issue Title: Applications of Particulate Carriers in Drug Delivery: Challenges and Future Perspectives



Alexander Orekhov
(Russia)

Issue Title: Convenient, Traditional and Alternative Therapies for Cardiovascular Disorders



Laurent Peyrin-Biroulet / Silvio Danese
(France / Italy)

Issue Title: Novel Targets for Therapeutic Intervention in Inflammatory Bowel Disease



Emma Piacentini / Lidietta Giorno
(Italy)

Issue Title: Membranes Technologies for Pharmaceutical Applications



Sandra Reznik
(USA)

Issue Title: Novel Pharmacotherapeutic Targets and Emerging Approaches to Prevent Preterm Birth



Luis Javier Cruz Ricondo
(Netherlands)

Issue Title: Targeting Nanomedicine to the Brain: Diagnostics, Prevention and Treatment



Seiji Shioda / Illana Gozes
(Japan / Israel)

Issue Title: Neuropeptides from Bench to Bedside



Alberto Signore
(Italy)

Issue Title: The future of Nuclear Medicine Imaging of Inflammation and Infections



Predrag Sikiric
(Hungary)

Issue Title: Stress and GI tract: Physiology, Pathophysiology, Pathology and Pharmacology



Pichini Simona / Francesco P. Busardo
(Italy)

Issue Title: Advances and Future Developments in Forensic Toxicology: From Standard Practices to new Psychoactive Substances



Eduardo Sobarzo-Sánchez
(Spain)

Issue Title: An Approach to the Theoretical and Experimental Design of Fused Compounds in the Treatment of Mental and Motor Dysfunctions



Karmen Stankov
(Serbia)

Issue Title: Discovery and Validation of Drug Targets Through Human Genetics and Epigenetics



Oriana Tabarrini / Serena Massari
(Italy)

Issue Title: Acting on Tat-mediated Transcription to Achieve a Long Term Control of HIV-1 Latency



Marios Themistocleous / Kostas Margetis / George Stranjalis
(Greece / USA / Greece)

Issue Title: Antiepileptic Drugs in Neurosurgical Practice



Dimitris Tousoulis / Evangelos Oikonomou
(Greece)

Issue Title: Statins Beyond Lipid Lowering Effects



Ravichandra Vemuri
(Australia)

Issue Title: Novel Interventional Targets for Gastrointestinal and Metabolic disorders



Dimitrios Vrachatis / Manolis Vavuranakis / Dimitrios Tousoulis
(Greece)

Issue Title: Antiplatelet and Anticoagulation Treatment in Special Populations



Junchao Wei / Jianxun Ding
(China)

Issue Title: Advanced Antibacterial Materials & Interfaces



Robert Weissert
(Germany)

Issue Title: Multiple Sclerosis – Therapeutics and Novel Approaches for Therapy



JiuChang Zhong / Gavin Oudit
(China / Canada)

Issue Title: Targeting the Apelin Pathway as a Novel Therapeutic Approach for Cardiovascular Disease



Lixin Zhu
(USA)

Issue Title: Modernizations, Applications and Efficacies of Herbal Medicine





Advertisement
Highly Potent Active Pharmaceutical Ingredients 2017Global Biotechnology Congress 2017Drug Discovery and Therapy World Congress 20174th Microbiome R&D and Business Collaboration Forum: Europe

Related Journals




Related eBooks



Webmaster Contact: urooj@benthamscience.org Copyright © 2017 Bentham Science